Ensign Peak Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.68M Buy
88,745
+23,063
+35% +$1.52M 0.01% 544
2026
Q1
$4.68M Buy
65,682
+12,470
+23% +$983K 0.01% 550
2025
Q4
$4.36M Sell
53,212
-9,526
-15% -$742K 0.01% 543
2025
Q3
$4.71M Buy
62,738
+14,630
+30% +$1.09M 0.01% 603
2025
Q2
$3.56M Sell
48,108
-32,643
-40% -$2.27M 0.01% 717
2025
Q1
$6.52M Buy
80,751
+1,961
+2% +$169K 0.01% 569
2024
Q4
$6.16M Buy
78,790
+10,770
+16% +$915K 0.01% 594
2024
Q3
$6.38M Sell
68,020
-47,875
-41% -$4.02M 0.01% 559
2024
Q2
$9.03M Buy
115,895
+27,363
+31% +$2.23M 0.02% 470
2024
Q1
$8.05M Sell
88,532
-50,118
-36% -$4.17M 0.01% 506
2023
Q4
$10.7M Sell
138,650
-17,831
-11% -$1.25M 0.02% 424
2023
Q3
$10.6M Buy
156,481
+606
+0.4% +$44.1K 0.02% 374
2023
Q2
$12.7M Buy
155,875
+9,483
+6% +$757K 0.03% 368
2023
Q1
$12M Buy
+146,392
New +$10.5M 0.03% 376

Other funds holding GEHC

Ensign Peak Advisors's GEHC Position: Q2 2026 in Review

Ensign Peak Advisors increased its GE HealthCare (GEHC) stake by 35% in Q2 2026, buying an estimated $1.52M and bringing the position to 88,745 shares worth $5.68M. The position accounts for 0.01% of the portfolio, ranked #544.

Ensign Peak Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $12.7M in Q2 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Ensign Peak Advisors held 88,745 shares of GE HealthCare worth $5.68M as of Q2 2026.
  • Ensign Peak Advisors bought 23,063 GE HealthCare shares in Q2 2026, an estimated $1.52M.
  • GE HealthCare made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #544 holding.
  • Ensign Peak Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Ensign Peak Advisors's GE HealthCare position peaked at $12.7M in Q2 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.